Higher circulating insulin levels may facilitate tumour growth through stimulation of the insulin-like growth factor (IGF) signalling pathways as insulin ligands have demonstrated high affinity to IGF-1 receptors [15, 22–24]. The gene discussed is IGF1; the disease is neoplasm.